Cargando…

Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study

BACKGROUND: Post-transplant lymphoproliferative disorders (PTLD) are heterogeneous lymphoid disorders ranging from indolent polyclonal proliferations to aggressive lymphomas that can arise after solid organ transplantation (SOT) and allogeneic hematopoietic transplantation (allo-HSCT). METHODS: In t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lückemeier, Philipp, Radujkovic, Aleksandar, Holtick, Udo, Kurch, Lars, Monecke, Astrid, Platzbecker, Uwe, Herling, Marco, Kayser, Sabine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326719/ https://www.ncbi.nlm.nih.gov/pubmed/37427100 http://dx.doi.org/10.3389/fonc.2023.1208028

Ejemplares similares

Vital Hepatic Lymphoma Residuum or Excessive Immune Response? Challenging Treatment Decisions in a Patient With Systemic Lupus Erythematosus and Liver-Dominant Diffuse Large B-Cell Lymphoma: Case Report
por: Kurch, Lars, et al.
Publicado: (2022)

Erratum: Characterization and outcome of post-transplant lymphoproliferative disorders within a collaborative study
Publicado: (2023)

Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary Syndrome
por: Franke, Georg-Nikolaus, et al.
Publicado: (2021)

Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells—Report on Two Cases
por: Gerhardt, Kristin, et al.
Publicado: (2021)

Case Report: Large Granular Lymphocyte Leukemia (LGLL)—A Case Series of Challenging Presentations
por: Pflug, Natali, et al.
Publicado: (2022)

Mutations in JAK/STAT and NOTCH1 Genes Are Enriched in Post-Transplant Lymphoproliferative Disorders
por: Butzmann, Alexandra, et al.
Publicado: (2022)

What is known about palliative care in adult patients with allogeneic stem cell transplantation (allo-SCT)?
por: Simon, Steffen T., et al.
Publicado: (2021)

Production and Application of CAR T Cells: Current and Future Role of Europe
por: Vucinic, Vladan, et al.
Publicado: (2021)

Biological Difference Between Epstein–Barr Virus Positive and Negative Post-transplant Lymphoproliferative Disorders and Their Clinical Impact
por: Ferla, Valeria, et al.
Publicado: (2020)

Case Report: Successful Chimeric Antigen Receptor T Cell Therapy in Haploidentical-Allogeneic Stem Cell Transplant Patients With Post-Transplant Lymphoproliferative Disorder
por: Yan, Nan, et al.
Publicado: (2021)

Successful Treatment of Central Nervous System Post-Transplant Lymphoproliferative Disease With a Reduced Dose of High-Dose Methotrexate
por: Albusoul, Linda, et al.
Publicado: (2022)

Editorial: Genomics of Lymphoproliferative Disease
por: Maura, Francesco, et al.
Publicado: (2021)

Post-transplant lymphoproliferative disease
por: Dharnidharka, Vikas R., et al.
Publicado: (2009)

Pre-transplant weight loss predicts inferior outcome after allogeneic stem cell transplantation in patients with myelodysplastic syndrome
por: Radujkovic, Aleksandar, et al.
Publicado: (2015)

Lack of Viral Load Within Chronic Lymphoproliferative Disorder of Natural Killer Cells: What Is Outside the Leukemic Clone?
por: Giussani, Edoardo, et al.
Publicado: (2021)

Atypical presentation of patients with chronic myeloid leukemia in chronic phase—Case report
por: Ramdohr, Florian, et al.
Publicado: (2022)

Ocular post-transplant lymphoproliferative disorder
por: Chen, Yun-Wen, et al.
Publicado: (2015)

Post-transplant lymphoproliferative disease of the larynx
por: Vandjelovic, Nathan D, et al.
Publicado: (2019)

Management of post-transplant lymphoproliferative disorders
por: Dierickx, Daan, et al.
Publicado: (2019)

Treatment Advances in EBV Related Lymphoproliferative Diseases
por: Lv, Kebing, et al.
Publicado: (2022)

Dysregulation of FBW7 in malignant lymphoproliferative disorders
por: Wan, Xin, et al.
Publicado: (2022)

Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation
por: Asleh, Rabea, et al.
Publicado: (2022)

Burden and Needs of Patients with Severe GvHD from the Supportive and Palliative Care Perspective—A Literature Review
por: Wenzel, Freya, et al.
Publicado: (2021)

Post-transplantation lymphoproliferative disorder with gastrointestinal involvement
por: Inayat, Faisal, et al.
Publicado: (2018)

Radical surgery and venetoclax plus azacitidine in an octogenarian with acute myeloid leukemia
por: Ramdohr, Florian, et al.
Publicado: (2022)

Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases
por: Hui, Kwai Fung, et al.
Publicado: (2019)

Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals
por: Shindiapina, Polina, et al.
Publicado: (2020)

Zanubrutinib Treatment of Central Nervous System Posttransplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
por: Yang, Ting-Ting, et al.
Publicado: (2021)

Post-transplant lymphoproliferative disease after pediatric kidney transplant
por: Fulchiero, Rosanna, et al.
Publicado: (2022)

Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is Feasible
por: Vucinic, Vladan, et al.
Publicado: (2020)

PD-1 Blockade Aggravates Epstein–Barr Virus(+) Post-Transplant Lymphoproliferative Disorder in Humanized Mice Resulting in Central Nervous System Involvement and CD4(+) T Cell Dysregulations
por: Volk, Valery, et al.
Publicado: (2021)

Developing a supportive and palliative care intervention for patients with allogeneic stem cell transplantation: protocol of a multicentre mixed-methods study (allo-PaS)
por: Pralong, Anne, et al.
Publicado: (2023)

Adult-Onset Still’s Disease With Extensive Lymphadenopathy Mimicking Lymphoproliferative Malignancy
por: Paul, Mishouri, et al.
Publicado: (2021)

Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms
por: Barros, Mario Henrique M., et al.
Publicado: (2023)

Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation
por: Luft, Thomas, et al.
Publicado: (2021)

Clinical Characteristics of Monomorphic Post-transplant Lymphoproliferative Disorders
por: Choi, Jung-Hye, et al.
Publicado: (2010)

Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders
por: Morscio, Julie, et al.
Publicado: (2016)

Natural Killer Cells in Post-Transplant Lymphoproliferative Disorders
por: Nakid-Cordero, Cecilia, et al.
Publicado: (2021)

Polymorphic post-transplant lymphoproliferative disorder in a gilt
por: Tura, Giorgia, et al.
Publicado: (2019)

Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder
por: Markouli, Mariam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p13pq1vq72ipq7vrr2fuops8su